CAJ | 학술논문

神经胶质细胞瘤是恶性脑肿瘤中最常见的一种类型，约占中枢神经系统肿瘤的一半以上，且易复发。如何选择术后的治疗方案成为延长患者生存时间的关键。随着医学技术的发展，出现了放射性粒子近距离治疗和基因治疗等一些精确治疗手段。本文将对粒子治疗及基因治疗神经胶质瘤的现状分别阐述，结合其优劣势，探讨两者联合治疗的发展前景，以期更好地改善神经胶质瘤的预后。
신경효질세포류시악성뇌종류중최상견적일충류형，약점중추신경계통종류적일반이상，차역복발。여하선택술후적치료방안성위연장환자생존시간적관건。수착의학기술적발전，출현료방사성입자근거리치료화기인치료등일사정학치료수단。본문장대입자치료급기인치료신경효질류적현상분별천술，결합기우열세，탐토량자연합치료적발전전경，이기경호지개선신경효질류적예후。
Glioma is the most common type among the malignant brain tumors ,and it accounts for almost half of central nervous system tumors .In addition,one of characters of glioma is easy to relapse .The key to pro-long the patients′survival time is how to choose appropriate treatments after surgical resection .With the develop-ment of medical technology ,precise approaches to treat these tumors are applied ,including radioactive particle im-plantation in brachytherapy and gene therapy .In this paper ,we discuss the status of the two therapies respective-ly,analyzing their superiority and inferiority ,and explore the prospects for the development of combined therapy in order to improve the prognosis of glioma better .